These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16099335)

  • 21. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.
    Di Mario U; Borsey DQ; Contreas G; Prowse CV; Clarke BF; Andreani D
    Clin Exp Immunol; 1986 Jul; 65(1):57-65. PubMed ID: 2947762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy.
    Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
    Diabetes Res Clin Pract; 2008 Jan; 79(1):141-6. PubMed ID: 17716775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitus.
    Gargiulo P; Schiaffini R; Bosco D; Ciampalini P; Pantaleo A; Romani B; Arcieri P; Andreani D
    Diabet Med; 1997 Feb; 14(2):132-7. PubMed ID: 9047090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
    Gustavsson C; Agardh E; Bengtsson B; Agardh CD
    J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu; Markova OA; Grishin VL; Efimov VS
    Vestn Oftalmol; 2004; 120(3):29-31. PubMed ID: 15216770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fibrinogen-fibrin degradation products in diabetes mellitus].
    Alakhverdian R; Koev D
    Vutr Boles; 1987; 26(6):72-5. PubMed ID: 3125689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemorheological alterations in patients with diabetic retinopathy.
    Vekasi J; Marton ZS; Kesmarky G; Cser A; Russai R; Horvath B
    Clin Hemorheol Microcirc; 2001; 24(1):59-64. PubMed ID: 11345235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased protein carbonylation of red blood cell membrane in diabetic retinopathy.
    Margetis PI; Antonelou MH; Petropoulos IK; Margaritis LH; Papassideri IS
    Exp Mol Pathol; 2009 Aug; 87(1):76-82. PubMed ID: 19379730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus.
    Chetthakul T; Likitmaskul S; Plengvidhya N; Suwanwalaikorn S; Kosachunhanun N; Deerochanawong C; Krittiyawong S; Leelawatana R; Benjasuratwong Y; Bunnag P; Prathipanawatr T; Ngarmukos C; Mongkolsomlit S; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S17-26. PubMed ID: 17715830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors of diabetic retinopathy in type 2 diabetic patients.
    Cai XL; Wang F; Ji LN
    Chin Med J (Engl); 2006 May; 119(10):822-6. PubMed ID: 16732984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma prekallikrein, coagulation and fibrinolytic parameters in myeloma patients.
    Annichino-Bizzacchi JM; Sampaio CA
    Nouv Rev Fr Hematol (1978); 1992; 34(2):201-3. PubMed ID: 1502028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.
    Lee JH; Lee W; Kwon OH; Kim JH; Kwon OW; Kim KH; Lim JB
    Ann Clin Lab Sci; 2008; 38(4):361-7. PubMed ID: 18988929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
    Liinamaa MJ; Savolainen MJ
    Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
    J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of aspirin on hemorheological parameters of patients with diabetic retinopathy.
    Vekasi J; Koltai K; Gaal V; Toth A; Juricskay I; Kesmarky G
    Clin Hemorheol Microcirc; 2008; 39(1-4):385-9. PubMed ID: 18503149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.